NeuroPace Inc
Research NeuroPace Inc (NPCE) on Bullrun: market cap USD 485.44M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNPCE
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 485.44M
- Financial periodQ1 2026
- RevenueUSD 22.07M
- Net income-USD 6.69M
- Free cash flow-USD 6.02M
- Gross margin81.8%
Valuation Snapshot
latest market cap is USD 485.44M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 99.99M | -USD 21.47M | -USD 11.34M | 77.2% | -0.66 | USD 21.69M | USD 58.88M | USD 19.03M |
| FY2024 | USD 79.91M | -USD 27.14M | -USD 18.26M | 73.9% | -0.93 | USD 13.43M | USD 59.53M | USD 8.01M |
| FY2023 | USD 65.42M | -USD 32.96M | -USD 19.87M | 73.6% | -1.27 | USD 18.06M | USD 56.95M | USD 20.65M |
| FY2022 | USD 45.52M | -USD 47.08M | -USD 37.47M | 71.4% | -1.91 | USD 6.61M | USD 52.91M | USD 34.78M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 485.44M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 518.39M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 337.32M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 270.98M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 37.11M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 246.49M | n/a | n/a | n/a |
About NeuroPace Inc
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NeuroPace Inc's market cap?
NeuroPace Inc's market capitalization is USD 485.44M.
What does NeuroPace Inc do?
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories.